These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22072919)

  • 1. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
    Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
    Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
    PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
    Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
    Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
    J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
    Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
    Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
    Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
    Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
    Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
    Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
    Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
    Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
    Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
    Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
    Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.
    Yan L; Lin B; Gao L; Gao S; Liu C; Wang C; Wang Y; Zhang S; Iwamori M
    Int J Mol Sci; 2010 Nov; 11(11):4441-52. PubMed ID: 21151448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways.
    Liu D; Liu J; Lin B; Liu S; Hou R; Hao Y; Liu Q; Zhang S; Iwamori M
    Int J Mol Sci; 2012; 13(1):828-839. PubMed ID: 22312289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.
    Hao Y; Zhu L; Yan L; Liu J; Liu D; Gao N; Tan M; Gao S; Lin B
    Oncol Rep; 2017 Dec; 38(6):3355-3366. PubMed ID: 29130097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
    Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
    J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfection of alpha1, 2-fucosyltransferase gene increases the antigenic expression of Lewis y in ovarian cancer cell line RMG-I].
    Lin B; Hao YY; Wang DD; Zhu LC; Zhang SL; Saito M; Iwamori M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):284-9. PubMed ID: 18686606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [alpha1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-I cells].
    Hao YY; Lin B; Zhao Y; Zhang YH; Li FF; Diao B; Ou YL; Zhang SL
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2008 Dec; 41(6):435-42. PubMed ID: 19137814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.
    Li F; Lin B; Hao Y; Li Y; Liu J; Cong J; Zhu L; Liu Q; Zhang S
    Int J Mol Sci; 2010 Sep; 11(10):3748-59. PubMed ID: 21152298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
    Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
    Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.